Autonomic dysfunction in critically ill patients - An overview;Die autonome dysfunktion des intensivpatienten - Ein überblick

Intensivmedizin und Notfallmedizin

Volumn 37, Issue 1, 2000, Pages 7-18

  Schmidt, H B ^a   Heinroth, K M ^a   Muller Werdan U ^a   Kuhn, C ^a   Werdan, K ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Autonomic dysfunction; Baroreflex sensitivity; Chemoreflex sensitivity; Heart rate variability; Intensive care medicine

Indexed keywords

EID: 0002523284     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050003     Document Type: Article

References (58)

1. Winchell RJ, Hoydt DB (1997) Analysis of heart-rate-variability: a noninvasive predictor of death and poor outcome in patients with severe head injury. J Trauma 43(6):927-933
2. Garrard CS, Kontoyannis DA, Piepoli M (1993) Special analysis of heart rate variability in sepsis syndrome. Clin Auton Res 3:5-13
3. Witthaut R, Werdan K, Schuster HP (1998) Multiorgandysfunktions-Syndrom und Multiorganversagen. Diagnose, Prognose und Therapiekonzepte. Internist 39(5):493-501
4. Müller-Werdan U (1998) Akute septische Kardiomyopathie. Internist 39(5):467-478
5. Burtin P, Bollaert PE, Feldmann L et al. (1994) Prognosis of stroke patients undergoing mechanical ventilation. Intensive Care Med 20:32-36
6. Godin PJ, Buchmann TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107-1116
7. Schmidt H, Heinroth K, Werdan K: Autonomic dysfunction in critically ill patients. In: Vincent J-L (ed): Yearbook of Intensive Care and Emergency Medicine 1999. Springer, Berlin, Heidelberg, New York, Barcelona, Budapest, Hongkong, London, Milan, Paris, Santa Clara, Singapore, Tokyo, 417-536
8. Board of the European Society of Cardiology and North American Society of Pacing and Electrophysiology (1996) Eur Heart J 17:354-381
9. Bigger JT, Fleiss JL, Steinmann RC, Rolnitzky LM, Schneider WJ, Stein PK (1995) RR variability in healthy, middle-aged persons compared with patients with chronic heart disease or recent acute myocardial infarction. Circulation 91:1936-1944
10. Malik M (1998) Heart rate variability. Curr Opinion Cardiol 13:36-44
11. Heinroth KM, Kuhn C, Stache N, Witthaut R, Müller-Werdan U, Werdan K, Prondzinsky R (1999) Eingeschränkte Herzfrequenzvariabilität bei Patienten mit septischem und nichtseptischem Multiorgan-Dysfunktions-Syndrom. Intensivmed. 36:436-445
12. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrigton D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJS (1997) Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96:2586-2594
13. Maestri R, Pinna GD, Mortara AM, La Rovere MT, Tavazzi L (1998) Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques. JACC 31:344-351
14. Pitzalis MV, Mastropasqua F, Passantino A, Massari F, Ligurgo L, Forleo C, Balducci C, Lombardi F, Rizzon P (1998) Comparison between noninvasive indices of baroreceptor sensitivity and the phenylephrine method in post-myocardial infarction patients. Circulation 97:1362-1367
15. La Rovere MT, Bigger Jr JT, Marcus FI, Mortara AM, Schwartz PJ (1988) Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351:478-484
16. Hennersdorf M, Perings C, Kristovic M. Dees H, Hillebrand S, Holz B, Vester EB, Strauer BE (1997) Chemoreflex and baroreflex sensitivity among patients with survived sudden cardiac death. Z Kardiol 86, 196-203
17. Hohnloser S (1999) Untersuchung der Barorezeplorenfunktion. Dt Ärztebl 96:A1716-1719
18. Bigger Jr JT, La Rovere MT, Steinmann RC, Fleiss JL, Rottman JN, Rolnitzky LM, Schwartz PJ (1989) Comparison of baroreflex sensitivity and heart rate variability after myocardial infarction. JACC 14:1511-1518
19. Chua TP, Ponikowski PP, Webb-Peploe K, Harrigton D, Anker SD, Piepoli M, Coats AJS (1997) Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J 18:480-486
20. Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M, Ward De, Camm AJ (1992) Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 68(129):137-140
21. Chua TP, Clark AL, Amadi AA, Coats AU (1996) Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. JACC 27:650-657
22. 2 as a clinical test of the peripheral chemoreflex. J Appl Physiol 64:84-89
23. Read DJC (1966) A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 16:20-32
24. Hennersdorf M, Perings C, Hillebrand S, Holz B, Vester EG (1998) Chemoreflex sensitivity in patients with prior myocardical infarction with and without ventricular tachyarrhythmias. Circulation 96 (8, Suppl.): 130 (Abst)
25. Opitz H, Peschel T, Schmidt H (1996) Influence of systemic hypoxia and hypercapnia on cardiovascular parameters - noninvasively assessed in humans. Scripta Medica 67(2):31-38
26. Schmidt H, Opitz H, Peschel T, Francis D, Rauchhaus M, Werdan K (1998) The cardiac chemoreflex sensitivity measurement is impaired by respiration. Intensive Care Med 24 (Suppl. 1):520 (Abst)
27. Schmidt H, Opitz H (1999) Die kardiale Chemoreflexsensitivität in Abhängigkeit von verschiedenen Formen der Atmung. Z Kardiol 88 (1): in press
28. Schmidt HB, Rauchhaus M, Schmidt DS, Opitz H, Coats AJS, Werdan K (1999) Does the chemoreflex sensitizer almitrine impair the cardiac deand repolarisation properties (QT-interval)? Intensive Care Med 25 (Suppl. 1): 367 (Abst.)
29. Müller-Werdan U, Schumann H, Fuchs R. Reithmann C, Loppnow H, Koch S, Zimny-Arndt U, Chang He, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K (1997) Tumor necrosis factor-α (TNF-α) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthetasc (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol 29:2915-2923
30. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM et al. (1996) Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized crossover trial. Crit Care Med 24:1117-1124
31. Goldstein B, Fiser DH, Kelly MM, Mickelsen D, Ruttimann U, Pollack MM (1998) Decomplexification in critical illness and injury: relationship between heart rate variability, severity of illness, and outcome. Crit Care Med 26(2):352-357
32. Goldstein B, Kempski MH, DeKing D, Cox C, DeLong DJ, Kelly MM, Woolf PD (1996) Autonomic control of heart rate after brain injury in children. Crit Care Med 24(2):234-240
33. Allen CE, Menke JA, Hayes J (1995) Nonlinearity of heart rate in the neonate. Am J Perinatol 12(2):116-121
34. Ponikowski P, Chua TP, Piepoli M, Amadi AA, Harrigton D, Webb-Peploe K, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJS (1997) Chemoreceptor dependence of very low frequency rhythms in advanced chronic heart failure. Am J Physiol 272 (Heart Circ Physiol 41): H438-H447
35. Piepoli M, Gerrard C, Kontojannis D, Bernadi L (1995) A restored sympathetic modulation to the heart and peripheral circulation. Intensive Care Med 21: 112-119
36. Kennedy HL (1998) Heart rate variability - a potential, noninvasive prognostic index in the critically ill patient. Crit Care Med 26(2):213-214
37. Hogue Jr CW, Stein PK, Aposiolidou I, Lappas DG, Kleiger RE (1994) Alterations of temporal pattern of heart rate variability after coronary artery bypass graft surgery. Anaesthesiol 81 (6): 1356-1364
38. Dworschak M, Gasteiger P, Rapp HJ, van Ackern K (1997) Perioperative myocardial ischemia is associated with a prolonged cardiac dysfunction after non-cardiac surgery. Acta Anaesthesiol Scand 41 (10): 1247-1256
39. Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU. J Surg Res 63: 11-16
40. Kawamoto M, Shimokawa A, Takasaki M (1995) Effects of midazolam on heart rate variability during surgery under spinal anaesthesia. Anaesth Intensive Care 23 (4): 464-468
41. Komatsu T, Sing PK, Kimura T, Nishiwaki K, Bando K, Shimada Y (1995) Differential effects of ketamine and midazolam on heart rate variability. Can J Anaesth 42 (11): 1003-1009
42. Deutschman CRS, Harris AP, Fleisher LA (1994) Changes in heart rate variability under propofol anaesthesia: a possible explanation for propofol induced bradycardia. Anaesth Analg 79 (2): 373-377
43. Sellgren J, Biber B, Henriksson BA, Martner J, Ponten J (1992) The effects of propofol, methohexitone and insofluorane on the baroreceptor reflex in the cat. Acta Anaesthesiol Scand 36(8): 784-790
44. Sellgren J, Ejnell H, Elam M, Ponten J, Wallin BG (1994) Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. Anaesthesiol 80(4):534-544
45. Watanabe Y, Dohi S, Iida H, Ishiyama T, Tashiro T, Shimonaka H (1995) The effects of systemic bupivacaine on baroreflex sensitivity in dogs. Masui 44(8): 1097-1101
46. Pratt NG (1995) Pathophysiology of heart failure: neuroendocrine response. Crit Care Nurs Q 18(1):22-31
47. Eriksson LI (1996) Reduced hypoxic chemosensitivity in partially paralysed man. A new property of musle relaxants? Acta Anaesthesiol Scand 40(5):520-523
48. Chua TP, Harrigton D, Ponikowski P, Webb-Peploe K, Poole-Wilson PA, Coats AJS (1997) Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. JACC 29: 147-152
49. Ponikowski P, Chua TP, Amadi AA, Piepoli M, Harrigton D, Volterrani M, Colombo R, Mazzuero G, Giordano A, Coats AJS (1996) Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic heart failure. Am J Cardiol 77:1320-1326
50. Schmidt H, Opitz H, Peschel T, Francis D, Rauchhaus M, Werdan K (1998) Does almitrine-bismesylate elicit acute cardiovascular effects? Intensive Care Med 24 (Suppl. 1):43 (Abst)
51. Muret J, Clavier N, Beloucif S, Payen D (1997) Intubation and mechanical ventilation avoided by using almitrine bismesylate in an acute hypoxemic pneumonia. Intensive Care Med 23:1008-1012
52. Jolliet P, Bulpa P, Rith M, Ricou B, Lopez J, Chevrolet JC (1997) Additive beneficial effects of the prone position, nitride oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome. Crit Care Med 25:786-794
53. Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM (1993) Intensive management and treated of severe Guillain-Barré syndrome. Crit Care Med 21(3):433-446
54. Pfeiffer G, Netzer J (1998) Spectral analysis of heart rate and blood pressure in Guillain-Barré patients with respiratory failure. J Neurol Sci 150(1):39-48
55. Müller-Werdan U, Reithmann C, Werdan K (1996) Derangement of inotropic axes of the cardiomyocyte. In: Müller-Werdan U, Reithmann C, Werdan K (eds.) Cytokines and the heart: Molecular mechanisms of septic cardiomyopathy. R.G. Landes Company. Georgetown USA, Chapman & Hall, USA, Springer, Heidelberg, 189-214
56. Müller-Werdan U, Schumann H, Loppnow H, Fuchs R, Darmer D, Stadler J, Holtz J, Werdan K (1998) Endotoxin and tumor necrosis factor-α exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol 30: 1027-1036
57. Müller-Werdan U, Engelmann H, Werdan K (1998) Cardiodepression by tumor necrosis factor-α. Eur Cytokine Netw 9:689-691
58. Schmidt HB, Müller-Werdan U, Saworski J, Kühn C, Heinroth KM, Werdan K (1999) Beating rate variability (BRV) of spontaneously contracting cardiomyocytes (CM) is narrowed by endotoxin (LPS) but not by TNF-α. Intensive Care Med 25: Suppl 1:59 (Abst.)